Does Vaccine Confidence Mediate the Relationship between Vaccine Literacy and Influenza Vaccination? Exploring Determinants of Vaccination among Staff Members of Nursing Homes in Tuscany, Italy, during the COVID-19 Pandemic.
human influenza
influenza vaccination
mediation model
nursing homes
vaccine confidence
vaccine literacy
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
17 Aug 2023
17 Aug 2023
Historique:
received:
27
07
2023
revised:
11
08
2023
accepted:
16
08
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
Low coverage of influenza vaccination in nursing home (NH) staff may be attributed to factors such as vaccine confidence (VC) and vaccine literacy (VL). Our study aimed to evaluate the role of VL and VC in predicting the intention to get the influenza vaccine in a sample of employees of NHs in Tuscany, Italy. Data from staff members in Tuscany were collected using an online questionnaire that examined influenza vaccination history, intentions, demographic information, health status, and VL. Statistical analyses explored the relationships between VC, VL, and vaccination intentions. The study included 1794 respondents, (86.3%) and assistants/aides (58.1%), with a median age of 46 years. The intention to get vaccinated was significantly higher among those with health risk conditions, and there was a positive association between VC and VL, specifically its interactive/critical component. The mediation analysis showed that VC completely mediated the relationship between VL and the intention to get vaccinated, with significant effects observed in different subgroups. VC is a key factor that mediates the effect of VL on vaccine intention. These results suggest that interventions aimed at improving VL alone may not be sufficient to increase vaccine uptake unless VC is also addressed.
Sections du résumé
BACKGROUND
BACKGROUND
Low coverage of influenza vaccination in nursing home (NH) staff may be attributed to factors such as vaccine confidence (VC) and vaccine literacy (VL). Our study aimed to evaluate the role of VL and VC in predicting the intention to get the influenza vaccine in a sample of employees of NHs in Tuscany, Italy.
METHODS
METHODS
Data from staff members in Tuscany were collected using an online questionnaire that examined influenza vaccination history, intentions, demographic information, health status, and VL. Statistical analyses explored the relationships between VC, VL, and vaccination intentions.
RESULTS
RESULTS
The study included 1794 respondents, (86.3%) and assistants/aides (58.1%), with a median age of 46 years. The intention to get vaccinated was significantly higher among those with health risk conditions, and there was a positive association between VC and VL, specifically its interactive/critical component. The mediation analysis showed that VC completely mediated the relationship between VL and the intention to get vaccinated, with significant effects observed in different subgroups.
CONCLUSIONS
CONCLUSIONS
VC is a key factor that mediates the effect of VL on vaccine intention. These results suggest that interventions aimed at improving VL alone may not be sufficient to increase vaccine uptake unless VC is also addressed.
Identifiants
pubmed: 37631943
pii: vaccines11081375
doi: 10.3390/vaccines11081375
pmc: PMC10458978
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Vaccines (Basel). 2022 Oct 29;10(11):
pubmed: 36366341
PLoS One. 2019 Oct 31;14(10):e0224330
pubmed: 31671115
Nat Rev Immunol. 2023 May;23(5):267-268
pubmed: 36944755
BMC Public Health. 2023 Aug 8;23(1):1501
pubmed: 37553624
Ann Ig. 2020 May-Jun;32(3):205-222
pubmed: 32266359
Vaccines (Basel). 2019 Nov 29;7(4):
pubmed: 31795438
Vaccine. 2012 Feb 1;30(6):1064-70
pubmed: 22178521
J Hosp Infect. 2008 Sep;70(1):76-9
pubmed: 18602191
Syst Rev. 2022 Apr 26;11(1):78
pubmed: 35473819
Int J Environ Res Public Health. 2020 Mar 12;17(6):
pubmed: 32178426
Hum Vaccin Immunother. 2019;15(11):2552-2553
pubmed: 31013184
Vaccine. 2009 Jun 19;27(30):3935-44
pubmed: 19467744
Vaccines (Basel). 2020 Mar 30;8(2):
pubmed: 32235481
JAMA. 2020 Jul 28;324(4):335-336
pubmed: 32525519
Influenza Other Respir Viruses. 2017 Sep;11(5):356-366
pubmed: 28691237
Hum Vaccin Immunother. 2018 Mar 4;14(3):540-549
pubmed: 28708957
Microb Pathog. 2021 Mar;152:104554
pubmed: 33157216
Hum Vaccin Immunother. 2022 Dec 30;18(7):2158669
pubmed: 36534602
J Health Commun. 2011 Mar;16(3):227-9
pubmed: 21391044
Int J Environ Res Public Health. 2022 Apr 07;19(8):
pubmed: 35457297
Ann Intern Med. 2011 Jul 19;155(2):97-107
pubmed: 21768583
Vaccines (Basel). 2020 Oct 12;8(4):
pubmed: 33053868
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Vaccine. 2007 Jul 20;25(29):5283-9
pubmed: 17580099
J Am Med Dir Assoc. 2020 Jan;21(1):25-28.e2
pubmed: 31888863
Vaccine. 2016 Dec 20;34(52):6700-6706
pubmed: 27810314
PLoS Curr. 2015 Feb 25;7:
pubmed: 25789200
BMC Public Health. 2022 May 25;22(1):1049
pubmed: 35614428
Vaccine. 2008 May 12;26(20):2482-9
pubmed: 18407385
Vaccines (Basel). 2022 Apr 25;10(5):
pubmed: 35632438
Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2:93-96
pubmed: 24034492
Vaccines (Basel). 2023 Mar 04;11(3):
pubmed: 36992177
Vaccine. 2019 Feb 28;37(10):1260-1265
pubmed: 30738645
Diabetes Care. 2008 May;31(5):874-9
pubmed: 18299446
Clin Infect Dis. 2004 Aug 15;39(4):459-64
pubmed: 15356805